Last updated: January 10, 2023
Sponsor: Erasmus Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05391763
NL72939.078.20
NTR7620
Ages 18-80 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Female patient
- Scheduled for a bilateral prophylactic mastectomy in the Erasmus MC Academic BreastCancer Centre in Rotterdam
- Ability to give written consent
- Adequate understanding of Dutch language
Exclusion
Exclusion Criteria:
- History of diagnosis of invasive breast cancer or ductal carcinoma in situ (DCIS)
- Other malignancies
Study Design
Total Participants: 21
Study Start date:
January 01, 2022
Estimated Completion Date:
December 01, 2023
Study Description
Connect with a study center
Erasmus Medical Center
Rotterdam,
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.